Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday’s Mid-Day Session
Gainers
Assure Holdings Corp. (NASDAQ: IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday.
Recap: Athenex Q2 Earnings
Athenex (NASDAQ:ATNX) reported its Q2 earnings results on Thursday, July 28, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Athenex Announces Publication Of Data From Phase 3 Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel In Patients With Metastatic Breast Cancer In The Journal Of Clinical Oncology
Athenex Announces Publication of Data from Phase 3 Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients with Metastatic Breast Cancer in the Journal of Clinical Oncology
BUFFALO,
Athenex Receives Notice Of Allowance For U.S. Patent Titled ‘METHODS OF TREATING AND/OR PREVENTING ACTINIC KERATOSI’
https://patentcenter.uspto.gov/#!/applications/16804092/ifw/docs
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Gainers
Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
Stocks That Hit 52-Week Lows On Thursday
During the Thursday's session, 100 stocks hit new 52-week lows.
Merck, Athenex Join Forces To Evaluate Oraxol/Keytruda Combo In Lung Cancer
Athenex Inc (NASDAQ:ATNX) announced a clinical trial collaboration and supply agreement with Merck Co & Inc (NYSE:MRK). The agreement applies to the expansion…
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from mid-cap companies.
SVB Leerink Maintains Market Perform on Athenex, Raises Price Target to $3
SVB Leerink maintains Athenex (NASDAQ:ATNX) with a Market Perform and raises the price target from $1 to $3.